New Insights Into the Role of mTOR Signaling in the Cardiovascular System
Open accessThe DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Abstract
The mTOR (mechanistic target of rapamycin) is a master regulator of several crucial cellular processes, including protein synthesis, cellular growth, proliferation, autophagy, lysosomal function, and cell metabolism. mTOR interacts with specific adaptor proteins to form 2 multiprotein complexes, called mTORC1 (mTOR complex 1) and mTORC2 (mTOR complex 2). In the cardiovascular system, the mTOR pathway regulates both physiological and pathological processes in the heart. It is needed for embryonic cardiovascular development and for maintaining cardiac homeostasis in postnatal life. Studies involving mTOR loss-of-function models revealed that mTORC1 activation is indispensable for the development of adaptive cardiac hypertrophy in response to mechanical overload. mTORC2 is also required for normal cardiac physiology and ensures cardiomyocyte survival in response to pressure overload. However, partial genetic or pharmacological inhibition of mTORC1 reduces cardiac remodeling and heart failure in response to pressure overload and chronic myocardial infarction. In addition, mTORC1 blockade reduces cardiac derangements induced by genetic and metabolic disorders and has been reported to extend life span in mice. These studies suggest that pharmacological targeting of mTOR may represent a therapeutic strategy to confer cardioprotection, although clinical evidence in support of this notion is still scarce. This review summarizes and discusses the new evidence on the pathophysiological role of mTOR signaling in the cardiovascular system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
mTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.004 · Cited by 7,555
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Autophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,430
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766 · cited 1×
“Both partial genetic and pharmacological mTORC1 inhibition were shown to extend life span in lower organisms and in mammals.(21,22,24) Pharmacological inhibition of mTOR with rapamycin reduced age-related heart inflammation and fibrosis and improved energy metabolism.”
TFEB Links Autophagy to Lysosomal Biogenesis
Settembre, C., Di Malta, C., Polito, V. A., Arencibia, M. G., Vetrini, F., Erdin, S., Erdin, S. U., Huynh, T., Medina, D., Colella, P., et al. (2011) · Science · doi:10.1126/science.1204592 · Cited by 3,365 · cited 1×
“The latter regulates autophagy by enhancing the expression of autophagic proteins such as ATG7, which is fundamental for the initiation of autophagy.(45,57,58) However, mTORC1 activation in cardiomyocytes dramatically reduces ATG7 expression levels.”
Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
Sonenberg, N., & Hinnebusch, A. G. (2009) · Cell · doi:10.1016/j.cell.2009.01.042 · Cited by 3,304
Kim, D.-H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 2,986
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773 · cited 4×
“We previously demonstrated that mTORC1 activity is reduced in cardiomyocytes under these conditions through inhibition of Rheb.59 Reactivation of Rheb/mTORC1 inhibits autophagy through ATG7 downregulation and promotes cardiomyocyte death.59 In line with this evidence, we also found that inhibition of cardiac GSK-3β du…”
InfluentialSarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600 · cited 1×
“impairing both autophagosome and autolysosome formation.(50) mTORC1 phosphorylates ULK (unc-51-like kinase) 1 and ATG13 (autophagy-related gene 13), thereby inhibiting the activity of the ULK1–ATG13–FIP200 (focal adhesion kinase family interacting protein of 200 kDa) multiprotein complex, which is crucial for autophag…”
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., & Hall, M. N. (2004) · Nature Cell Biology · doi:10.1038/ncb1183 · Cited by 2,114
The machinery of macroautophagy
Feng, Y., He, D., Yao, Z., & Klionsky, D. J. (2014) · Cell Research · doi:10.1038/cr.2013.168 · Cited by 2,083
Nutrient-dependent mTORC1 Association with the ULK1–Atg13–FIP200 Complex Required for Autophagy
Hosokawa, N., Hara, T., Kaizuka, T., Kishi, C., Takamura, A., Miura, Y., Iemura, S.-I., Natsume, T., Takehana, K., Yamada, N., et al. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1248 · Cited by 2,076 · cited 1×
“mTORC1 phosphorylates ULK (unc-51-like kinase) 1 and ATG13 (autophagy-related gene 13), thereby inhibiting the activity of the ULK1–ATG13–FIP200 (focal adhesion kinase family interacting protein of 200 kDa) multiprotein complex, which is crucial for autophagosome formation.(51) In the presence of nutrients, phosphoryl…”
mTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.03.035 · Cited by 2,070
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020 · cited 2×
“Last, mTORC1 promotes a metabolic shift from fatty acid oxidation toward glycolysis by enhancing the expression of HIF-1α (hypoxiainducible factor-1α), which regulates the expression of genes involved in glycolysis.(40) Hearts of mice with cardiac raptor gene ablation display an increase in carbohydrate metabolism tog…”
A lysosome‐to‐nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
Settembre, C., Zoncu, R., Medina, D. L., Vetrini, F., Erdin, S., Erdin, S., Huynh, T., Ferron, M., Karsenty, G., Vellard, M. C., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.32 · Cited by 1,920
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action
Hara, K., Maruki, Y., Long, X., Yoshino, K.-I., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J., & Yonezawa, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00833-4 · Cited by 1,810
mTOR is a key modulator of ageing and age-related disease
Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M. (2013) · Nature · doi:10.1038/nature11861 · Cited by 1,676
Cardiac Fibrosis: The Fibroblast Awakens
Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E., & Blaxall, B. C. (2016) · Circulation Research · doi:10.1161/circresaha.115.306565 · Cited by 1,596 · cited 1×
“Many different profibrotic stimuli lead to mTOR activation in cardiac fibroblasts, and mTOR upregulation in this context is associated with an increase in collagen synthesis, fibroblast proliferation, and transformation of fibroblasts into myofibroblasts.(151) mTOR was also found to mediate the cardiac profibrotic by…”
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Matsui, Y., Takagi, H., Qu, X., Abdellatif, M., Sakoda, H., Asano, T., Levine, B., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/01.res.0000261924.76669.36 · Cited by 1,505
Self-citationmTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex
Cunningham, J. T., Rodgers, J. T., Arlow, D. H., Vazquez, F., Mootha, V. K., & Puigserver, P. (2007) · Nature · doi:10.1038/nature06322 · Cited by 1,488
Guertin, D. A., Stevens, D. M., Thoreen, C. C., Burds, A. A., Kalaany, N. Y., Moffat, J., Brown, M., Fitzgerald, K. J., & Sabatini, D. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.007 · Cited by 1,415
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384 · cited 2×
“Similarly, a stress response protein named REDD1 (regulated in development and DNA damage responses 1) activates TSC1/2 during hypoxia independently of AMPK.85 In addition, Roberts et al86 recently demonstrated that HK-II (hexokinase-II), a protein involved in the first step of glycolysis, increases autophagy and dimi…”
Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.055 · Cited by 1,377
Roczniak-Ferguson, A., Petit, C. S., Froehlich, F., Qian, S., Ky, J., Angarola, B., Walther, T. C., & Ferguson, S. M. (2012) · Science Signaling · doi:10.1126/scisignal.2002790 · Cited by 1,366
Regulation of TORC1 by Rag GTPases in nutrient response
Kim, E., Goraksha-Hicks, P., Li, L., Neufeld, T. P., & Guan, K.-L. (2008) · Nature Cell Biology · doi:10.1038/ncb1753 · Cited by 1,349 · cited 3×
“We previously demonstrated that mTORC1 activity is reduced in cardiomyocytes under these conditions through inhibition of Rheb.59 Reactivation of Rheb/mTORC1 inhibits autophagy through ATG7 downregulation and promotes cardiomyocyte death.59 In line with this evidence, we also found that inhibition of cardiac GSK-3β du…”
MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB
Martina, J. A., Chen, Y., Gucek, M., & Puertollano, R. (2012) · Autophagy · doi:10.4161/auto.19653 · Cited by 1,333
Phosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268 · cited 1×
“ERK 1/2 (extracellular signal–regulated kinase 1/2) and IKKβ (inhibitor of NF-κB [nuclear factor κB] kinase β) were also reported to mediate TSC1/2 inhibition in response to growth factors.(79,80)”
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A., & Sabatini, D. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.003 · Cited by 1,236
mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
Peterson, T. R., Sengupta, S. S., Harris, T. E., Carmack, A. E., Kang, S. A., Balderas, E., Guertin, D. A., Madden, K. L., Carpenter, A. E., Finck, B. N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.034 · Cited by 1,229
Peterson, T. R., Laplante, M., Thoreen, C. C., Sancak, Y., Kang, S. A., Kuehl, W. M., Gray, N. S., & Sabatini, D. M. (2009) · Cell · doi:10.1016/j.cell.2009.03.046 · Cited by 1,202
Eisen, H. J., Tuzcu, E. M., Dorent, R., Kobashigawa, J., Mancini, D., Valantine-von Kaeppler, H. A., Starling, R. C., Sørensen, K., Hummel, M., Lind, J. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022171 · Cited by 1,198
The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins
Harrington, L. S., Findlay, G. M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N. R., Cheng, S., Shepherd, P. R., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403069 · Cited by 1,123
Hsu, P. P., Kang, S. A., Rameseder, J., Zhang, Y., Ottina, K. A., Lim, D., Peterson, T. R., Choi, Y., Gray, N. S., Yaffe, M. B., et al. (2011) · Science · doi:10.1126/science.1199498 · Cited by 1,084
Tee, A. R., Manning, B. D., Roux, P. P., Cantley, L. C., & Blenis, J. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00506-2 · Cited by 1,080
The LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N., Manning, B. D., Lopez, L., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,077
Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways
Palmieri, M., Impey, S., Kang, H., di Ronza, A., Pelz, C., Sardiello, M., & Ballabio, A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr306 · Cited by 1,022
Kim, D.-H., Sarbassov, D. D., Ali, S. M., Latek, R. R., Guntur, K. V. P., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00114-x · Cited by 961
García-Martínez, J. M., & Alessi, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20081668 · Cited by 907
Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells
Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.815 · Cited by 887
Yu, Y., Yoon, S.-O., Poulogiannis, G., Yang, Q., Ma, X. M., Villén, J., Kubica, N., Hoffman, G. R., Cantley, L. C., Gygi, S. P., et al. (2011) · Science · doi:10.1126/science.1199484 · Cited by 854
The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway
Chantranupong, L., Scaria, S. M., Saxton, R. A., Gygi, M. P., Shen, K., Wyant, G. A., Wang, T., Harper, J. W., Gygi, S. P., & Sabatini, D. M. (2016) · Cell · doi:10.1016/j.cell.2016.02.035 · Cited by 843 · cited 1×
“sor for mTORC1) inhibits mTORC1 through the GATOR1/2 pathway in response to low arginine levels.(94,95) A recent work”
Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1
Wang, S., Tsun, Z.-Y., Wolfson, R. L., Shen, K., Wyant, G. A., Plovanich, M. E., Yuan, E. D., Jones, T. D., Chantranupong, L., Comb, W., et al. (2015) · Science · doi:10.1126/science.1257132 · Cited by 824
Sekulić, A., Hudson, C. C., Homme, J. L., Yin, P., Otterness, D. M., Karnitz, L. M., & Abraham, R. T. (2000) · PubMed · Cited by 810
Shah, O. J., Wang, Z., & Hunter, T. (2004) · Current Biology · doi:10.1016/j.cub.2004.08.026 · Cited by 798
mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle
Ben-Sahra, I., Hoxhaj, G., Ricoult, S. J. H., Asara, J. M., & Manning, B. D. (2016) · Science · doi:10.1126/science.aad0489 · Cited by 795
Nazio, F., Strappazzon, F., Antonioli, M., Bielli, P., Cianfanelli, V., Bordi, M., Gretzmeier, C., Dengjel, J., Piacentini, M., Fimia, G. M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2708 · Cited by 780
Menon, S., Dibble, C. C., Talbott, G., Hoxhaj, G., Valvezan, A. J., Takahashi, H., Cantley, L. C., & Manning, B. D. (2014) · Cell · doi:10.1016/j.cell.2013.11.049 · Cited by 766
S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth
Dorrello, N. V., Peschiaroli, A., Guardavaccaro, D., Colburn, N. H., Sherman, N. E., & Pagano, M. (2006) · Science · doi:10.1126/science.1130276 · Cited by 731
Nojima, H., Tokunaga, C., Eguchi, S., Oshiro, N., Hidayat, S., Yoshino, K.-I., Hara, K., Tanaka, N., Avruch, J., & Yonezawa, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200665200 · Cited by 682
Martina, J. A., Diab, H. I., Lishu, L., Jeong-A, L., Patange, S., Raben, N., & Puertollano, R. (2014) · Science Signaling · doi:10.1126/scisignal.2004754 · Cited by 677
SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1
Rebsamen, M., Pochini, L., Stasyk, T., de Araújo, M. E. G., Galluccio, M., Kandasamy, R. K., Snijder, B., Fauster, A., Rudashevskaya, E. L., Bruckner, M., et al. (2015) · Nature · doi:10.1038/nature14107 · Cited by 673
Regulation of mTORC1 and its impact on gene expression at a glance
Laplante, M., & Sabatini, D. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.125773 · Cited by 667
With TOR, Less Is More: A Key Role for the Conserved Nutrient-Sensing TOR Pathway in Aging
Kapahi, P., Chen, D., Rogers, A. N., Katewa, S. D., Li, P. W.-L., Thomas, E. L., & Kockel, L. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.05.001 · Cited by 660
Activation of mTORC2 by Association with the Ribosome
Zinzalla, V., Stracka, D., Oppliger, W., & Hall, M. N. (2011) · Cell · doi:10.1016/j.cell.2011.02.014 · Cited by 654
IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway
Lee, D.-F., Kuo, H.-P., Chen, C.-T., Hsu, J.-M., Chou, C.-K., Wei, Y., Sun, H.-L., Li, L.-Y., Ping, B., Huang, W.-C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.058 · Cited by 637
An Emerging Role of mTOR in Lipid Biosynthesis
Laplante, M., & Sabatini, D. M. (2009) · Current Biology · doi:10.1016/j.cub.2009.09.058 · Cited by 620
PKC-α regulates cardiac contractility and propensity toward heart failure
Braz, J. C., Gregory, K., Pathak, A., Zhao, W., Sahin, B., Klevitsky, R., Kimball, T. F., Lorenz, J. N., Nairn, A. C., Liggett, S. B., et al. (2004) · Nature Medicine · doi:10.1038/nm1000 · Cited by 595
TOS Motif-Mediated Raptor Binding Regulates 4E-BP1 Multisite Phosphorylation and Function
Schalm, S. S., Fingar, D. C., Sabatini, D. M., & Blenis, J. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00329-4 · Cited by 520
McMullen, J. R., Sherwood, M. C., Tarnavski, O., Zhang, L., Dorfman, A. L., Shioi, T., & Izumo, S. (2004) · Circulation · doi:10.1161/01.cir.0000130641.08705.45 · Cited by 518
Shang, L., Chen, S., Du, F., Li, S., Zhao, L., & Wang, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100844108 · Cited by 517
The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2
Huang, J., Dibble, C. C., Matsuzaki, M., & Manning, B. D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00289-08 · Cited by 511
Chantranupong, L., Wolfson, R. L., Orozco, J. M., Saxton, R. A., Scaria, S. M., Bar-Peled, L., Spooner, E., Isasa, M., Gygi, S. P., & Sabatini, D. M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.014 · Cited by 466 · cited 1×
“deactivates GATOR (GAP activity toward Rags) 2, a positive regulator of mTORC1.(92,93) Once inhibited, GATOR2 fails to”
Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice
Shioi, T., McMullen, J. R., Tarnavski, O., Converso, K., Sherwood, M. C., Manning, W. J., & Izumo, S. (2003) · Circulation · doi:10.1161/01.cir.0000057979.36322.88 · Cited by 462
Mammalian Target of Rapamycin Signaling in Cardiac Physiology and Disease
Sciarretta, S., Volpe, M., & Sadoshima, J. (2014) · Circulation Research · doi:10.1161/circresaha.114.302022 · Cited by 453
Self-citationUse of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy
Mancini, D., Pinney, S., Burkhoff, D., LaManca, J., Itescu, S., Burke, E., Edwards, N., Oz, M., & Marks, A. R. (2003) · Circulation · doi:10.1161/01.cir.0000070421.38604.2b · Cited by 442
Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1
Dibble, C. C., Asara, J. M., & Manning, B. D. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00735-09 · Cited by 423
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy
Wang, Z., Zhang, X.-J., Ji, Y.-X., Zhang, P., Deng, K.-Q., Gong, J., Ren, S., Wang, X., Chen, I., Wang, H., et al. (2016) · Nature Medicine · doi:10.1038/nm.4179 · Cited by 386
PtdIns(3,4,5) P 3-Dependent Activation of the mTORC2 Kinase Complex
Liu, P., Gan, W., Chin, Y. R., Ogura, K., Guo, J., Zhang, J., Wang, B., Blenis, J., Cantley, L. C., Toker, A., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0460 · Cited by 382
Ramos, F. J., Chen, S. C., Garelick, M. G., Dai, D.-F., Liao, C.-Y., Schreiber, K. H., MacKay, V. L., An, E. H., Strong, R., Ladiges, W. C., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003802 · Cited by 349 · cited 4×
“The involvement of ULK1 in mediating mTOR-dependent inhibition of autophagy has been demonstrated in the hearts of cardiac raptor knockout mice and in animal models of genetic cardiomyopathy as well.(16,54) In response to amino acid starvation, Figure 3.”
InfluentialSKAR Links Pre-mRNA Splicing to mTOR/S6K1-Mediated Enhanced Translation Efficiency of Spliced mRNAs
Ma, X. M., Yoon, S.-O., Richardson, C. J., Jülich, K., & Blenis, J. (2008) · Cell · doi:10.1016/j.cell.2008.02.031 · Cited by 337
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice
Zhang, D., Contu, R., Latronico, M. V. G., Zhang, J. L., Rizzi, R., Catalucci, D., Miyamoto, S., Huang, K., Ceci, M., Gu, Y., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43008 · Cited by 337
Sestrins inhibit mTORC1 kinase activation through the GATOR complex
Parmigiani, A., Nourbakhsh, A., Ding, B., Wang, W., Kim, Y. C., Akopiants, K., Guan, K.-L., Karin, M., & Budanov, A. V. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.019 · Cited by 336
Hexokinase-II Positively Regulates Glucose Starvation-Induced Autophagy through TORC1 Inhibition
Roberts, D. J., Tan-Sah, V. P., Ding, E. Y., Smith, J. M., & Miyamoto, S. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.019 · Cited by 330
Dai, D., Karunadharma, P. P., Chiao, Y. A., Basisty, N., Crispin, D., Hsieh, E. J., Chen, T., Gu, H., Djukovic, D., Raftery, D., et al. (2014) · Aging Cell · doi:10.1111/acel.12203 · Cited by 328
Late-life rapamycin treatment reverses age-related heart dysfunction
Flynn, J. M., O'Leary, M. N., Zambataro, C. A., Academia, E. C., Presley, M. P., Garrett, B. J., Zykovich, A., Mooney, S. D., Strong, R., Rosen, C. J., et al. (2013) · Aging Cell · doi:10.1111/acel.12109 · Cited by 311
Mechanism of arginine sensing by CASTOR1 upstream of mTORC1
Saxton, R. A., Chantranupong, L., Knockenhauer, K. E., Schwartz, T. U., & Sabatini, D. M. (2016) · Nature · doi:10.1038/nature19079 · Cited by 308
Wu, J. J., Liu, J., Chen, E. B., Wang, J. J., Cao, L., Narayan, N., Fergusson, M. M., Rovira, I. I., Allen, M., Springer, D. A., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.030 · Cited by 307
A comprehensive glossary of autophagy-related molecules and processes (2ndedition)
Klionsky, D. J., Baehrecke, E. H., Brumell, J. H., Chu, C. T., Codogno, P., Cuervo, A. M., Debnath, J., Deretic, V., Elazar, Z., Eskelinen, E.-L., et al. (2011) · Autophagy · doi:10.4161/auto.7.11.17661 · Cited by 294
Sciarretta, S., Zhai, P., Shao, D., Maejima, Y., Robbins, J., Volpe, M., Condorelli, G., & Sadoshima, J. (2012) · Circulation · doi:10.1161/circulationaha.111.078212 · Cited by 292
Self-citationRegulation of PIK3C3/VPS34 complexes by MTOR in nutrient stress-induced autophagy
Yuan, H.-X., Russell, R. C., & Guan, K.-L. (2013) · Autophagy · doi:10.4161/auto.26058 · Cited by 291
Rapamycins: Mechanisms of Action and Cellular Resistance
Huang, S., Bjornsti, M.-A., & Houghton, P. J. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.3.360 · Cited by 287
Marin, T. M., Keith, K., Davies, B., Conner, D. A., Guha, P., Kalaitzidis, D., Wu, X., Lauriol, J., Wang, B., Bauer, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44972 · Cited by 282
Amino Acid-Dependent mTORC1 Regulation by the Lysosomal Membrane Protein SLC38A9
Jung, J., Genau, H. M., & Behrends, C. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00125-15 · Cited by 266
ZKSCAN3 Is a Master Transcriptional Repressor of Autophagy
Chauhan, S., Goodwin, J. G., Chauhan, S., Manyam, G., Wang, J., Kamat, A. M., & Boyd, D. D. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.024 · Cited by 266
Tti1 and Tel2 Are Critical Factors in Mammalian Target of Rapamycin Complex Assembly
Kaizuka, T., Hara, T., Oshiro, N., Kikkawa, U., Yonezawa, K., Takehana, K., Iemura, S.-I., Natsume, T., & Mizushima, N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121699 · Cited by 255
Shende, P., Plaisance, I., Morandi, C., Pellieux, C., Berthonneche, C., Zorzato, F., Krishnan, J., Lerch, R., Hall, M. N., Rüegg, M. A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.977066 · Cited by 239
Differential Roles of GSK-3β During Myocardial Ischemia and Ischemia/Reperfusion
Zhai, P., Sciarretta, S., Galeotti, J., Volpe, M., & Sadoshima, J. (2011) · Circulation Research · doi:10.1161/circresaha.111.249532 · Cited by 218 · cited 4×
“Although previous work demonstrated that pharmacological inhibition of mTORC1 before the ischemic phase reduces final ischemia/reperfusion damage,(135) other studies showed that mTORC1 inhibition is ineffective when administered at the time of reperfusion injury.(84) Prolonged rapamycin treatment also decreases cardia…”
InfluentialSelf-citationLu, Z., Xu, X., Hu, X., Fassett, J., Zhu, G., Tao, Y., Li, J., Huang, Y., Zhang, P., Zhao, B., et al. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2940 · Cited by 215 · cited 1×
“necrosis, inflammation, and cardiac dysfunction after ischemia/ reperfusion.(140) These results are in accordance with previous compelling data from Dhingra et al(141) demonstrating that mTOR”
Buss, S. J., Muenz, S., Riffel, J. H., Malekar, P., Hagenmueller, M., Weiss, C. S., Bea, F., Bekeredjian, R., Schinke-Braun, M., Izumo, S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.031 · Cited by 213
Wang, W., Zhang, F., Xia, Y., Zhao, S., Yan, W., Wang, H., Lee, Y., Li, C., Zhang, L., Lian, K., et al. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00114.2016 · Cited by 211
Adverse events associated with mTOR inhibitors
Pallet, N., & Legendre, C. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.752814 · Cited by 198
Inhibitory effect of mTOR activator MHY1485 on autophagy: suppression of lysosomal fusion
Choi, Y. J., Park, Y. J., Park, J. Y., Jeong, H. O., Kim, D. H., Ha, Y. M., Kim, J. M., Song, Y. M., Heo, H.-S., Yu, B. P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043418 · Cited by 192 · cited 1×
“In addition, mTORC1 directly impairs the activity of lysosomal proteins required for lysosomal lumen acidification, such as the proton pump v-ATPase,(65) thereby affecting lysosomal function and the process of autophagosome–lysosome fusion, namely autophagic flux.(66)”
miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation
Li, Z., Song, Y., Liu, L., Hou, N., An, X., Zhan, D., Li, Y., Zhou, L., Li, P., Yu, L., et al. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2015.95 · Cited by 191
HAUSENLOY, D. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.04.011 · Cited by 188
Shinmura, K., Tamaki, K., Sano, M., Murata, M., Yamakawa, H., Ishida, H., & Fukuda, K. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.018 · Cited by 173
MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis
Su, M., Wang, J., Wang, C., Wang, X., Dong, W., Qiu, W., Wang, Y., Zhao, X., Zou, Y., Song, L., et al. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.187 · Cited by 172
GSK-3α is a central regulator of age-related pathologies in mice
Zhou, J., Freeman, T. A., Ahmad, F., Shang, X., Mangano, E., Gao, E., Farber, J., Wang, Y., Ma, X.-L., Woodgett, J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64398 · Cited by 169
Guo, R., Zhang, Y., Turdi, S., & Ren, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.013 · Cited by 164
Mechanisms of mTOR inhibitor resistance in cancer therapy
Carew, J. S., Kelly, K. R., & Nawrocki, S. T. (2011) · Targeted Oncology · doi:10.1007/s11523-011-0167-8 · Cited by 161
Das, A., Durrant, D., Koka, S., Salloum, F. N., Xi, L., & Kukreja, R. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.521062 · Cited by 153
Chen, S. N., Czernuszewicz, G., Tan, Y., Lombardi, R., Jin, J., Willerson, J. T., & Marian, A. J. (2012) · Circulation Research · doi:10.1161/circresaha.112.270207 · Cited by 147
Das, A., Salloum, F. N., Durrant, D., Ockaili, R. A., & Kukreja, R. C. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.09.007 · Cited by 136
Xu, X., Hua, Y., Sreejayan, N., Zhang, Y., & Ren, J. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs055 · Cited by 135
Song, X., Kusakari, Y., Xiao, C.-Y., Kinsella, S. D., Rosenberg, M. A., Scherrer-Crosbie, M., Hara, K., Rosenzweig, A., & Matsui, T. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00338.2010 · Cited by 133
Aoyama, T., Matsui, T., Novikov, M., Park, J., Hemmings, B., & Rosenzweig, A. (2005) · Circulation · doi:10.1161/01.cir.0000160352.58142.06 · Cited by 129
EPRS is a critical mTORC1–S6K1 effector that influences adiposity in mice
Arif, A., Terenzi, F., Potdar, A. A., Jia, J., Sacks, J., China, A., Halawani, D., Vasu, K., Li, X., Brown, J. M., et al. (2017) · Nature · doi:10.1038/nature21380 · Cited by 128
mTORC2 Regulates Cardiac Response to Stress by Inhibiting MST1
Sciarretta, S., Zhai, P., Maejima, Y., Del Re, D. P., Nagarajan, N., Yee, D., Liu, T., Magnuson, M. A., Volpe, M., Frati, G., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.010 · Cited by 122
Self-citationMechanistic Target of Rapamycin Complex 2 Protects the Heart From Ischemic Damage
Völkers, M., Konstandin, M. H., Doroudgar, S., Toko, H., Quijada, P. J., Din, S., Joyo, A. Y., Ornelas, L., Samse, K., Thuerauf, D. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003638 · Cited by 116
A Gene Signature-Based Approach Identifies mTOR as a Regulator of p73
Rosenbluth, J. M., Mays, D. J., Pino, M. F., Tang, L. J., & Pietenpol, J. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00305-08 · Cited by 112
Depletion of Rictor, an essential protein component of m TORC 2, decreases male lifespan
Lamming, D. W., Mihaylova, M. M., Katajisto, P., Baar, E. L., Yilmaz, O. H., Hutchins, A., Gultekin, Y., Gaither, R., & Sabatini, D. M. (2014) · Aging Cell · doi:10.1111/acel.12256 · Cited by 111
Zhu, Y., Pires, K. M. P., Whitehead, K. J., Olsen, C. D., Wayment, B. E., Zhang, Y. C., Bugger, H., Ilkun, O. L., Litwin, S. E., Thomas, G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054221 · Cited by 111
Li, Z.-L., Woollard, J. R., Ebrahimi, B., Crane, J. A., Jordan, K. L., Lerman, A., Wang, S.-M., & Lerman, L. O. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.244061 · Cited by 108
Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1
Völkers, M., Toko, H., Doroudgar, S., Din, S., Quijada, P. J., Joyo, A. Y., Ornelas, L., Joyo, E., Thuerauf, D. J., Konstandin, M. H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301455110 · Cited by 106
Bénard, L., Oh, J. G., Cacheux, M., Lee, A., Nonnenmacher, M. E., Matasic, D. S., Kohlbrenner, E., Kho, C., Pavoine, C., Hajjar, R. J., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.020678 · Cited by 99
Rag GTPases are cardioprotective by regulating lysosomal function
Kim, Y. C., Park, H. W., Sciarretta, S., Mo, J.-S., Jewell, J. L., Russell, R. C., Wu, X., Sadoshima, J., & Guan, K.-L. (2014) · Nature Communications · doi:10.1038/ncomms5241 · Cited by 97
Self-citationp38γ and δ promote heart hypertrophy by targeting the mTOR-inhibitory protein DEPTOR for degradation
González‐Terán, B., López, J. A., Rodríguez, E., Leiva‐Vega, L., Martínez-Martínez, S., Bernal, J. A., Jiménez‐Borreguero, L. J., Redondo, J. M., Vázquez, J., & Sabio, G. (2016) · Nature Communications · doi:10.1038/ncomms10477 · Cited by 94
Modulation of mTOR signaling as a strategy for the treatment of Pompe disease
Lim, J., Li, L., Shirihai, O. S., Trudeau, K. M., Puertollano, R., & Raben, N. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201606547 · Cited by 94
CITED4 induces physiologic hypertrophy and promotes functional recovery after ischemic injury
Bezzerides, V. J., Platt, C., Lerchenmüller, C., Paruchuri, K., Oh, N. L., Xiao, C., Cao, Y., Mann, N., Spiegelman, B. M., & Rosenzweig, A. (2016) · JCI Insight · doi:10.1172/jci.insight.85904 · Cited by 93
Morales, C. R., Li, D. L., Pedrozo, Z., May, H. I., Jiang, N., Kyrychenko, V., Cho, G. W., Kim, S. Y., Wang, Z. V., Rotter, D., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aad5736 · Cited by 89
Völkers, M., Doroudgar, S., Nguyen, N., Konstandin, M. H., Quijada, P. J., Din, S., Ornelas, L., Thuerauf, D. J., Gude, N. A., Friedrich, K., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201303183 · Cited by 77
Wu, X., Cao, Y., Nie, J., Liu, H., Lu, S., Hu, X., Zhu, J., Zhao, X., Chen, J., Chen, X., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.012 · Cited by 74
Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy
Shende, P., Xu, L., Morandi, C., Pentassuglia, L., Heim, P., Lebboukh, S., Berthonneche, C., Pedrazzini, T., Kaufmann, B. A., Hall, M. N., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv252 · Cited by 69
Di, R., Wu, X., Chang, Z., Zhao, X., Feng, Q., Lu, S., Luan, Q., Hemmings, B. A., Li, X., & Yang, Z. (2011) · Biochemical Journal · doi:10.1042/bj20110033 · Cited by 68
Das, A., Salloum, F. N., Filippone, S. M., Durrant, D. E., Rokosh, G., Bolli, R., & Kukreja, R. C. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0486-5 · Cited by 68
Shen, W.-H., Chen, Z., Shi, S., Chen, H., Zhu, W., Penner, A., Bu, G., Li, W., Boyle, D. W., Rubart, M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801510200 · Cited by 67
Pharmacological Modulation of Autophagy During Cardiac Stress
Sciarretta, S., Zhai, P., Volpe, M., & Sadoshima, J. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182575f61 · Cited by 67
Self-citationFolliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation
Hasumi, Y., Baba, M., Hasumi, H., Huang, Y. K., Lang, M., Reindorf, R., Oh, H., Sciarretta, S., Nagashima, K., Haines, D. C., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu286 · Cited by 66
Self-citationPivotal Role of mTORC2 and Involvement of Ribosomal Protein S6 in Cardioprotective Signaling
Yano, T., Ferlito, M., Aponte, A. M., Kuno, A., Miura, T., Murphy, E., & Steenbergen, C. (2014) · Circulation Research · doi:10.1161/circresaha.114.303562 · Cited by 66
DDiT4L promotes autophagy and inhibits pathological cardiac hypertrophy in response to stress
Simonson, B., Subramanya, V., Chan, M. C., Zhang, A., Franchino, H. A., Ottaviano, F. G., Mishra, M. K., Knight, A. C., Hunt, D., Ghiran, I. C., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aaf5967 · Cited by 64
Dual Specificity Phosphatase 4 Mediates Cardiomyopathy Caused by Lamin A/C (LMNA) Gene Mutation
Choi, J. C., Wu, W., Muchir, A., Iwata, S., Homma, S., & Worman, H. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.404541 · Cited by 63
Taneike, M., Nishida, K., Omiya, S., Zarrinpashneh, E., Misaka, T., Kitazume-Taneike, R., Austin, R., Takaoka, M., Yamaguchi, O., Gambello, M. J., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152628 · Cited by 57 · cited 1×
“sociated with an impairment of autophagic flux, which were reversed by pharmacological autophagy reactivation.(127)”
Oka, S., Hirata, T., Suzuki, W., Naito, D., Chen, Y., Chin, A., Yaginuma, H., Saito, T., Nagarajan, N., Zhai, P., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.807735 · Cited by 57
Self-citationMazelin, L., Panthu, B., Nicot, A.-S., Belotti, E., Tintignac, L. A. J., Teixeira, G., Zhang, Q., Risson, V., Baas, D., Delaune, E. A., et al. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.04.011 · Cited by 56
Lian, H., Ma, Y., Feng, J., Dong, W., Yang, Q., Lü, D., & Zhang, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044946 · Cited by 53
Dhingra, R., Gang, H., Wang, E. Y., Biala, A. K., Aviv, Y., Margulets, V., Tee, A. R., & Kirshenbaum, L. A. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000061 · Cited by 53
Tamai, T., Yamaguchi, O., Hikoso, S., Takeda, T., Taneike, M., Oka, T., Oyabu, J., Murakawa, T., Nakayama, H., Uno, Y., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.423640 · Cited by 51
Boosting autophagy in the diabetic heart: a translational perspective.
Sciarretta, S., Boppana, V. S., Umapathi, M., Frati, G., & Sadoshima, J. (2015) · PubMed · doi:10.3978/j.issn.2223-3652.2015.07.02 · Cited by 50
Self-citationThe Akt-mTOR axis is a pivotal regulator of eccentric hypertrophy during volume overload
Ikeda, M., Ide, T., Fujino, T., Matsuo, Y., Arai, S., Saku, K., Kakino, T., Oga, Y., Nishizaki, A., & Sunagawa, K. (2015) · Scientific Reports · doi:10.1038/srep15881 · Cited by 49
Gidlöf, O., Johnstone, A. L., Bader, K., Khomtchouk, B. B., O’Reilly, J. J., Celik, S., Booven, D. J. V., Wahlestedt, C., Metzler, B., & Erlinge, D. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004076 · Cited by 47
De novo RRAGC mutation activates mTORC1 signaling in syndromic fetal dilated cardiomyopathy
Long, P. A., Zimmermann, M. T., Kim, M., Evans, J. M., Xu, X., & Olson, T. M. (2016) · Human Genetics · doi:10.1007/s00439-016-1685-3 · Cited by 46
Haller, S. T., Yan, Y., Drummond, C. A., Xie, J. X., Tian, J., Kennedy, D. J., Shilova, V. Y., Xie, Z., Liu, J., Cooper, C. J., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004106 · Cited by 42
Pires, K. M. P., Buffolo, M., Schaaf, C., Symons, J. D., Cox, J. E., Abel, E. D., Selzman, C. H., & Boudina, S. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.10.001 · Cited by 41
Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy
Li, Q., Xie, J., Wang, B., Li, R., Bai, J., Ding, L., Gu, R., Wang, L. Y., & Xu, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148480 · Cited by 40
Is Load-Induced Ventricular Hypertrophy Ever Compensatory?
Schiattarella, G. G., Hill, T. M., & Hill, J. A. (2017) · Circulation · doi:10.1161/circulationaha.117.030730 · Cited by 39
mTORC2 Phosphorylation of Akt1: A Possible Mechanism for Hydrogen Sulfide-Induced Cardioprotection
Zhou, Y., Wang, D., Gao, X., Lew, K. S., Richards, M., & Wang, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099665 · Cited by 38
Ai, F., Chen, M., Yu, B., et al. (2015) · PubMed · Cited by 36
Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway
Ackermann, M. A., King, B., Lieberman, N. A. P., Bobbili, P. J., Rudloff, M. W., Berndsen, C., Wright, N. T., Hecker, P. A., & Kontrogianni‐Konstantopoulos, A. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.08.004 · Cited by 34
Gómez-Salinero, J. M., López-Olañeta, M. M., Ortiz-Sánchez, P., Larrasa-Alonso, J., Gatto, A., Felkin, L. E., Barton, P. J. R., Navarro‐Lérida, I., del Pozo, M. Á., García‐Pavía, P., et al. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.09.010 · Cited by 31
Zhang, H.-M., Diaz, V., Walsh, M. E., & Zhang, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-00970-7 · Cited by 31
The critical role of Sestrin 1 in regulating the proliferation of cardiac fibroblasts
Sun, G., Xue, R., Yao, F., Liu, D., Huang, H., Chen, C., Li, Y., Zeng, J., Zhang, G., Dong, Y., et al. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.11.011 · Cited by 30
Clinical impact of myocardial mTORC1 activation in nonischemic dilated cardiomyopathy
Yano, T., Shimoshige, S., Miki, T., Tanno, M., Mochizuki, A., Fujito, T., Yuda, S., Muranaka, A., Ogasawara, M., Hashimoto, A., et al. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.022 · Cited by 27
Zhou, N., Ma, B., Stoll, S., Hays, T. T., & Qiu, H. (2017) · Aging Cell · doi:10.1111/acel.12653 · Cited by 26
Lassaletta, A. D., Elmadhun, N. Y., Zanetti, A. V. D., Feng, J., Anduaga, J., Gohh, R., Sellke, F. W., & Bianchi, C. F. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2013.09.059 · Cited by 24
Cited by
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Self-citationSignaling pathways and targeted therapy for myocardial infarction
Zhang, Q., Wang, L., Wang, S., Cheng, H., Xu, L., Pei, G., Wang, Y., Fu, C., Jiang, Y., He, C., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00925-z · Cited by 831
Neinast, M., Murashige, D., & Arany, Z. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114455 · Cited by 714
The Translational Landscape of the Human Heart
van Heesch, S., Witte, F., Schneider-Lunitz, V., Schulz, J. F., Adami, E., Faber, A. B., Kirchner, M., Maatz, H., Blachut, S., Sandmann, C.-L., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.010 · Cited by 626
The quest to slow ageing through drug discovery
Partridge, L., Fuentealba, M., & Kennedy, B. K. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0067-7 · Cited by 468
Metadata
- Authors
- Sciarretta, S., Forte, M., Frati, G., & Sadoshima, J.
- Venue
- Circulation Research
- Published
- 2018-02-02
- Volume
- 122
- Issue
- 3
- Pages
- 489-505
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2789055329
- Cited by
- 491
- References
- 166
- FWCI
- 16.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.